Inflammasomes as Potential Therapeutic Targets to Prevent Chronic Active Viral Myocarditis-Translating Basic Science...

Area of Science:

• Cardiology
• Immunology
• Molecular Biology

Background:

• Acute myocarditis is a life-threatening condition often following viral infections.
• Progression to chronic active myocarditis or dilated cardiomyopathy can occur, especially with mixed infections.
• Inflammasomes play a dual role in host defense and chronic inflammation in myocarditis.

Purpose of the Study:

• To review the role of inflammasome pathways in myocarditis progression.
• To discuss novel and established therapeutic strategies for myocarditis.
• To emphasize early identification of patients at risk for chronic disease.

Main Methods:

• Review of current understanding of inflammasome pathways in myocarditis.
• Summary of therapeutic strategies targeting inflammatory and anti-fibrotic mechanisms.
• Case report illustrating progression from acute to chronic myocarditis.

Main Results:

• Inflammasomes are crucial for controlling acute infection but can cause myocardial injury when overactivated.
• Persistent inflammasome activation contributes to heart failure, fibrosis, and dilated cardiomyopathy.
• Emerging therapies offer potential to balance pathogen clearance and limit chronic cardiac damage.

Conclusions:

• Early identification of patients at risk for chronic myocarditis is crucial.
• Targeting inflammasome pathways and fibrosis holds promise for improved myocarditis outcomes.
• Balancing pathogen clearance with limiting chronic damage is key for effective myocarditis treatment.